Paul Berg

Specialty: Molecular Biology

Location: Global

Tier: UNRANKED

H-Index: 0

Years Active: 0

Hospital Affiliations

• Stanford University - Member

Key Publications

1. "Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial." - JAMA (2023)
2. "Erratum: Erratum." - Clin Med Insights Circ Respir Pulm Med (2022)
3. "Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial." - Lancet (2009)
4. "How genomics can help biodiversity conservation." - Trends Genet (2023)
5. "The dual-use conundrum." - Science (2012)

Knowledge Graph Relationships

Paul Berg is a Molecular Biology specialist affiliated with Stanford University. Authored 5 scholarly articles.